DNAprint Genomics (DNAG)

[frogdreaming]

Virgil, Fair enough, you were unable to get your point across due to the difficulty of translating mockery into text.

Why don't we start over?

What are the possible sets of circumstances that might lead a competitive multi-national pharmaceutical company to relinquish it's license for a 'slam dunk' multi-billion dollar drug?

Next step. Of those sets of circumstances, which ones would prevent one of it's multi-national competitors from snapping up the license immediately it became available?

What circumstances can be conceived that prevented all of the potential players in the global pharmaceutical business from entering into a bidding war to obtain said 'slam dunk' muti-billion dollar drug?

Once we have pared the list of scenarios down to those that meet these tests we can analyze each one independently and sort out how we got to such a state.

regards,
frog